Literature DB >> 23281113

Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts.

Chunyan Yang1, Huirong Pan, Minxi Wei, Xiao Zhang, Nan Wang, Ying Gu, Hailian Du, Jun Zhang, Shaowei Li, Ningshao Xia.   

Abstract

The hepatitis E virus (HEV) capsid protein has been demonstrated to be able to assemble into particles in vitro. However, this process and the mechanism of protein-protein interactions during particle assembly remain unclear. In this study, we investigated the assembly mechanism of HEV structural protein subunits, the capsid protein p239 (aa368-606), using analytical ultracentrifugation. It was the first to observe that the p239 can form particles in 4M urea as a result of supplementation with salt, including ammonium sulfate [(NH₄)₂SO₄], sodium sulfate (Na₂SO₄), sodium chloride (NaCl), and ammonium chloride (NH₄Cl). Interestingly, it is the ionic strength that determines the efficiency of promoting particle assembly. The assembly rate was affected by temperature and salt concentration. When (NH₄)₂SO₄ was used, assembling intermediates of p239 with sedimentation coefficient values of approximately 5 S, which were mostly dodecamers, were identified for the first time. A highly conserved 28-aa region (aa368-395) of p239 was found to be critical for particle assembly, and the hydrophobic residues Leu³⁷², Leu³⁷⁵, and Leu³⁹⁵ of p239 was found to be critical for particle assembly, which was revealed by site-directed mutagenesis. This study provides new insights into the assembly mechanism of native HEV, and contributes a valuable basis for further investigations of protein assembly by hydrophobic interactions under denaturing conditions.
Copyright © 2012 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23281113      PMCID: PMC3595462          DOI: 10.1002/pro.2213

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

1.  Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes.

Authors:  L Xing; K Kato; T Li; N Takeda; T Miyamura; L Hammar; R H Cheng
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

2.  Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway.

Authors:  Li Xing; Tian-Cheng Li; Naoyuki Mayazaki; Martha N Simon; Joseph S Wall; Mary Moore; Che-Yen Wang; Naokazu Takeda; Takaji Wakita; Tatsuo Miyamura; R Holland Cheng
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

3.  Mutation of interfacial residues disrupts subunit folding and particle assembly of Physalis mottle tymovirus.

Authors:  Mahadevaiah Umashankar; Mathur R N Murthy; Handanahal S Savithri
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

4.  Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques.

Authors:  M L Johnson; J J Correia; D A Yphantis; H R Halvorson
Journal:  Biophys J       Date:  1981-12       Impact factor: 4.033

5.  [Construction and application of an Escherichia coli high effective expression vector with an enhancer].

Authors:  W X Luo; J Zhang; H J Yang; S W Li; X Y Xie; S Q Pang; S J Li; N S Xia
Journal:  Sheng Wu Gong Cheng Xue Bao       Date:  2000-09

6.  Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein.

Authors:  J Z Zhang; M H Ng; N S Xia; S H Lau; X Y Che; T N Chau; S T Lai; S W Im
Journal:  J Med Virol       Date:  2001-06       Impact factor: 2.327

7.  Viral hepatitis during pregnancy.

Authors:  S P Jaiswal; A K Jain; G Naik; N Soni; D S Chitnis
Journal:  Int J Gynaecol Obstet       Date:  2001-02       Impact factor: 3.561

Review 8.  Hepatitis E virus.

Authors:  Suzanne U Emerson; Robert H Purcell
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

9.  Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route.

Authors:  M S Balayan; A G Andjaparidze; S S Savinskaya; E S Ketiladze; D M Braginsky; A P Savinov; V F Poleschuk
Journal:  Intervirology       Date:  1983       Impact factor: 1.763

10.  Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome.

Authors:  A W Tam; M M Smith; M E Guerra; C C Huang; D W Bradley; K E Fry; G R Reyes
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  5 in total

Review 1.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  The development of a recombinant hepatitis E vaccine HEV 239.

Authors:  Shao-Wei Li; Qinjian Zhao; Ting Wu; Shu Chen; Jun Zhang; Ning-Shao Xia
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Hepatitis E virus: Current epidemiology and vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Xiaotian Hao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

4.  Escherichia coli-derived virus-like particles in vaccine development.

Authors:  Xiaofen Huang; Xin Wang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  NPJ Vaccines       Date:  2017-02-09       Impact factor: 7.344

Review 5.  Subviral particle as vaccine and vaccine platform.

Authors:  Ming Tan; Xi Jiang
Journal:  Curr Opin Virol       Date:  2014-03-21       Impact factor: 7.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.